Gangnam-gu/SEOUL - Crypto Med Innovation today announced that it is teaming up with a Chinese therapeutics company to accelerate automated T-Cell therapy and gene therapeutics.

Gangnam-gu/SEOUL - Crypto Med Innovation today announced that it is the final stages on its product design for portable and compact sanitizer device.

Gangnam-gu/SEOUL - Crypto Med Innovation today announced that it would be trialing peptide dyes for surgical and therapeutic use targeting key nerves for head and neck surgery.

GANGNAM-GU/SEOUL - Crypto Med Innovation today announced the important appointment of Gary McBride as its new Chief Creation Officer and will be based in Seoul.

Gangnam-gu/SEOUL - Crypto Med Innovation, a South Korean biotech company today announced that it will trial its newly developed COVID-19 testing kits.

Gangnam-gu/SEOUL - Crypto Med Innovation today announced it plans to provide a generic version of buprenorphine and naloxone as part of Firm’s data-generating medication system.

Gangnam-gu/SEOUL - Crypto Med Innovation today announced that is it teaming up with an Indian Bio-Tech company to research and develop anti-viral flu remedies.

Gangnam-gu/SEOUL - Crypto Med Innovation today announced plans to be carbon neutral by the end of 2021, by both reducing and offsetting the company’s carbon emissions.

SEOUL - Crypto Med Innovation of Seoul today donated US$1 million to an emergency response fund to aid with the coronavirus outbreak which has the world locked down.

GANGNAM-GU/SEOUL - Crypto Med Innovation today announced that it will launch its platform to provide insights for diabetic patients in clinical trials for neuropathic pain.